S&P 500   3,298.57 (+0.84%)
DOW   26,588.22 (+0.26%)
QQQ   276.52 (+1.80%)
AAPL   114.91 (+3.34%)
MSFT   205.12 (+1.20%)
FB   283.00 (+5.73%)
GOOGL   1,546.79 (+2.38%)
AMZN   3,197.40 (+1.09%)
TSLA   416.76 (+2.65%)
NVDA   522.74 (+3.50%)
BABA   309.16 (+0.40%)
CGC   18.37 (+0.16%)
GE   7.39 (-0.40%)
MU   50.16 (+0.32%)
AMD   78.38 (+2.59%)
T   26.78 (+1.06%)
F   8.01 (+4.03%)
ACB   3.87 (+1.04%)
GILD   57.56 (-1.98%)
NFLX   483.00 (-0.67%)
NIO   29.97 (+8.94%)
BA   147.29 (-0.57%)
DIS   119.86 (+1.17%)
S&P 500   3,298.57 (+0.84%)
DOW   26,588.22 (+0.26%)
QQQ   276.52 (+1.80%)
AAPL   114.91 (+3.34%)
MSFT   205.12 (+1.20%)
FB   283.00 (+5.73%)
GOOGL   1,546.79 (+2.38%)
AMZN   3,197.40 (+1.09%)
TSLA   416.76 (+2.65%)
NVDA   522.74 (+3.50%)
BABA   309.16 (+0.40%)
CGC   18.37 (+0.16%)
GE   7.39 (-0.40%)
MU   50.16 (+0.32%)
AMD   78.38 (+2.59%)
T   26.78 (+1.06%)
F   8.01 (+4.03%)
ACB   3.87 (+1.04%)
GILD   57.56 (-1.98%)
NFLX   483.00 (-0.67%)
NIO   29.97 (+8.94%)
BA   147.29 (-0.57%)
DIS   119.86 (+1.17%)
S&P 500   3,298.57 (+0.84%)
DOW   26,588.22 (+0.26%)
QQQ   276.52 (+1.80%)
AAPL   114.91 (+3.34%)
MSFT   205.12 (+1.20%)
FB   283.00 (+5.73%)
GOOGL   1,546.79 (+2.38%)
AMZN   3,197.40 (+1.09%)
TSLA   416.76 (+2.65%)
NVDA   522.74 (+3.50%)
BABA   309.16 (+0.40%)
CGC   18.37 (+0.16%)
GE   7.39 (-0.40%)
MU   50.16 (+0.32%)
AMD   78.38 (+2.59%)
T   26.78 (+1.06%)
F   8.01 (+4.03%)
ACB   3.87 (+1.04%)
GILD   57.56 (-1.98%)
NFLX   483.00 (-0.67%)
NIO   29.97 (+8.94%)
BA   147.29 (-0.57%)
DIS   119.86 (+1.17%)
S&P 500   3,298.57 (+0.84%)
DOW   26,588.22 (+0.26%)
QQQ   276.52 (+1.80%)
AAPL   114.91 (+3.34%)
MSFT   205.12 (+1.20%)
FB   283.00 (+5.73%)
GOOGL   1,546.79 (+2.38%)
AMZN   3,197.40 (+1.09%)
TSLA   416.76 (+2.65%)
NVDA   522.74 (+3.50%)
BABA   309.16 (+0.40%)
CGC   18.37 (+0.16%)
GE   7.39 (-0.40%)
MU   50.16 (+0.32%)
AMD   78.38 (+2.59%)
T   26.78 (+1.06%)
F   8.01 (+4.03%)
ACB   3.87 (+1.04%)
GILD   57.56 (-1.98%)
NFLX   483.00 (-0.67%)
NIO   29.97 (+8.94%)
BA   147.29 (-0.57%)
DIS   119.86 (+1.17%)
Log in
NASDAQ:BNR

Burning Rock Biotech Stock Forecast, Price & News

$30.05
-0.44 (-1.44 %)
(As of 10/29/2020 11:36 AM ET)
Add
Compare
Today's Range
$29.33
Now: $30.05▼
$30.60
50-Day Range N/A
52-Week Range
$18.64
Now: $30.05▼
$32.40
Volume403 shs
Average Volume183,067 shs
Market Capitalization$3.06 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Burning Rock Biotech develops solutions for precision medicine in oncology and early cancer detection in the People's Republic of China. The company provides companion diagnostics for targeted therapy and immunotherapy, benign/malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. It also offers liquid biopsy; OncoScreen Plus, a test for therapy and immunotherapy; LungPlasma, a test for non-small cell lung cancer, including various genes that have a targeted therapy; ColonCore for testing gastrointestinal cancers; and HRDCore for testing genes associated with homologous recombination deficiency. Burning Rock Biotech was founded in 2014 and is headquartered in Guangzhou, China.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.63 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:BNR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.brbiotech.com
Phone86 20 3403 7871
Employees705

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares101,778,000
Market Cap$3.06 billion
Next Earnings Date11/20/2020 (Confirmed)
OptionableNot Optionable
$30.05
-0.44 (-1.44 %)
(As of 10/29/2020 11:36 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BNR News and Ratings via Email

Sign-up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Burning Rock Biotech (NASDAQ:BNR) Frequently Asked Questions

When is Burning Rock Biotech's next earnings date?

Burning Rock Biotech is scheduled to release its next quarterly earnings announcement on Friday, November 20th 2020.
View our earnings forecast for Burning Rock Biotech.

How can I listen to Burning Rock Biotech's earnings call?

Burning Rock Biotech will be holding an earnings conference call on Friday, November 20th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Burning Rock Biotech's earnings last quarter?

Burning Rock Biotech Limited (NASDAQ:BNR) released its earnings results on Tuesday, August, 11th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.20) by $0.18. The company had revenue of $15.14 million for the quarter.
View Burning Rock Biotech's earnings history.

Who are some of Burning Rock Biotech's key competitors?

Some companies that are related to Burning Rock Biotech include Guardant Health (GH), InVitae (NVTA), Natera (NTRA), ELEKTA AB/ADR (EKTAY), CareDx (CDNA), Veracyte (VCYT), Genetron (GTH), Castle Biosciences (CSTL), Personalis (PSNL), RadNet (RDNT), Fulgent Genetics (FLGT), Renalytix AI (RNLX), Progenity (PROG), DermTech (DMTK) and Centogene (CNTG).
View all competitors.

What other stocks do shareholders of Burning Rock Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Burning Rock Biotech investors own include Tiziana Life Sciences (TLSA), Teck Resources (TECK), Herman Miller (MLHR) and Immunic (IMUX).

Who are Burning Rock Biotech's key executives?

Burning Rock Biotech's management team includes the following people:
  • Dr. Shaokun Chuai, COO & Director (Age 41)
  • Mr. Yusheng Han, Founder, Chairman & CEO (Age 42)
  • Mr. Jinxiang Li, CFO, Principal Accounting Officer, Compliance Officer & Director (Age 35)
  • Dr. Zhihong Zhang, Chief Technology Officer (Age 44)
  • Mr. Hao Liu, Chief Medical Officer (Age 46)

When did Burning Rock Biotech IPO?

(BNR) raised $196 million in an IPO on Friday, June 12th 2020. The company issued 13,500,000 shares at $13.50-$15.50 per share. Morgan Stanley, BofA Securities and Cowen acted as the underwriters for the IPO and CMBI and Tiger Brokers were co-managers.

What is Burning Rock Biotech's stock symbol?

Burning Rock Biotech trades on the NASDAQ under the ticker symbol "BNR."

How do I buy shares of Burning Rock Biotech?

Shares of BNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Burning Rock Biotech's stock price today?

One share of BNR stock can currently be purchased for approximately $30.05.

How big of a company is Burning Rock Biotech?

Burning Rock Biotech has a market capitalization of $3.06 billion. Burning Rock Biotech employs 705 workers across the globe.

What is Burning Rock Biotech's official website?

The official website for Burning Rock Biotech is www.brbiotech.com.

How can I contact Burning Rock Biotech?

Burning Rock Biotech's mailing address is 601 BUILDING 3 STANDARD INDUSTRIAL UNIT2, GUANGZHOU F4, 510005. The company can be reached via phone at 86 20 3403 7871.

This page was last updated on 10/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.